Company intelligence / Profile preview

BioDuro-Sundia

Irvine, California, United Statesbioduro.com ↗

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

BioDuro-Sundia does not develop its own clinical pipeline but enables thousands of pharmaceutical companies to advance programs from early discovery through IND-enabling studies and commercial manufacturing. It has completed hundreds of GMP batches across multiple FDA-approved products at its facilities.

Modalities: Small moleculePeptideOligonucleotideAntibody-drug conjugateBiologicProteinPROTAC drug discovery
Industry: Drug Discovery Services

Beyond the preview

Go deeper on BioDuro-Sundia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioDuro-Sundia.

Explore the full profile